Efficacy and Safety of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel: Post Hoc Analysis by Baseline Disease Severity. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. s497, 2024. DOI: 10.25251/skin.8.supp.497. Disponível em: https://skin.dermsquared.com/skin/article/view/3068. Acesso em: 17 apr. 2026.